n-methylaspartate has been researched along with Epilepsies, Myoclonic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auvin, S; Dulac, O; Vallée, L | 1 |
| Rho, JM | 1 |
1 review(s) available for n-methylaspartate and Epilepsies, Myoclonic
| Article | Year |
|---|---|
Basic science behind the catastrophic epilepsies.
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Corticotropin-Releasing Hormone; Epilepsies, Myoclonic; Epilepsy; Humans; Infant; Infant, Newborn; Kynurenic Acid; Kynurenine; N-Methylaspartate; Quinolinic Acid; Receptors, N-Methyl-D-Aspartate; Serotonin; Spasms, Infantile; Tryptophan | 2004 |
1 other study(ies) available for n-methylaspartate and Epilepsies, Myoclonic
| Article | Year |
|---|---|
Do SCN1A mutations protect from hippocampal sclerosis?
Topics: Animals; Calcium; DNA Mutational Analysis; Epilepsies, Myoclonic; Genotype; Hippocampus; Humans; Infant; Mice; Mice, Mutant Strains; N-Methylaspartate; NAV1.1 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Neurons; Phenotype; Sclerosis; Seizures, Febrile; Sodium Channels | 2008 |